Regenerative medicine and tissue engineering are searching for a novel stem cell based therapeutic strategy that will allow for efficient treatment or even potential replacement of damaged organs. The pluripotent stem cell (PSC) which gives rise to cells from all three germ lineages, seems to be the most ideal candidate for such therapies. PSC could be extracted from developing embryos. However, since this source of stem cells for potential therapeutic purposes remains controversial, stem cell researchers look for PSC that could be isolated from the adult tissues or generated from already differentiated cells. True PSC should possess both potential for multilineage differentiation in vitro and, more importantly, also be able to complement in vivo blastocyst development. This review will summarize current approaches and limitations to isolate PSC from adult tissues or, alternatively, to generate it by nuclear reprogramming from already differentiated somatic cells.
Introduction
Recent advances in stem cell purification as well as successes with clinical application of stem cells in hematological transplantology or dermatology set a solid basis for the further development of regenerative medicine. It has been proposed that stem cells may play in the future a crucial role in the treatment of several disorders resulting from tissue/organ damage (e.g., heart infarct, stroke, diabetes, Parkinsonism). Stem cells could be employed both to regenerate damaged tissues (e.g., to supply new cardiomyocytes in infracted heart, insulin producing cells, new neurons) and ultimately, perhaps to also create ex vivo organ fragments and even entire organs. Successful development of such therapeutic strategies could completely change routine clinical approaches in cardiology, neurology, diabetology and organ transplantation.
At this point, however, we still do not have an ideal stem cell candidate for regenerative medicine and it becomes obvious that the stem cell compartment itself is heterogenous showing a broad spectrum in developmental hierarchy ( Figure 1 , Table I ). Since the average organ (e.g., heart, liver) is composed from several types of cells, the most valuable for regeneration would be stem cells that i) on one side possess high self-renewal and regenerative potential and ii) on the other would be able to contribute to tissues from different germ layers (e.g., organ parenchyma, connective tissue, vessels and nerves). Thus, it is not questionable that the most ideal candidate would be pluripotent stem cell (PSC). PSC are very well described in developing embryos (e.g., in inner cell mass of blastocyst or clonote). However, since potential application of stem cells isolated from embryos for therapy is controversial, the search for an alternative source of PSC isolated from adult tissues or generated by nuclear reprogramming continues. This review will summarize current approaches and limitations to obtain such cells.
Developmental hierarchy of the stem cell compartment -from the totipotent zygote to monopotent tissue committed stem cells
Stem cells are endowed with the property of self-renewal and the ability to differentiate into cells that are committed to particular developmental pathways. The compartment of stem cells itself is organized in a hierarchical way from the most primitive (totipotent) to already differentiated tissue-committed (monopotent) stem cells. Table I show the developmental hierarchy of stem cells. It begins with the most primitive totipotent stem cell, the zygote, which is the result of the fusion of two germ cells (oocyte and sperm) during the process of fertilization. As a totipotent stem cell, the zygote is able to give rise to both the embryo and the placenta. The "artificial" counterpart of the totipotent zygote is referred to as a clonote and can be created in the laboratory with an experimental approach known as somatic nuclear transfer, involving removal of the nucleus from a somatic cell and its insertion/transfer into an enucleated oocyte [1] . The first blastomers that derive from the first division of the zygote or clonote are still totipotent stem cells. In support of this is the well-known fact that the first blastomers, if separated from each other, can give rise to two independent embryos [2] , as seen in the case of monozygotic siblings.
When the blastomers have divided into the 32-cell stage, the embryo is known as a morula. Cells which form the morula have already lost their totipotentcy and are now pluripotent. The pluripotent stem cell (PSC) is defined as being able to contribute to the development of the embryo but has lost the capacity to form the trophoblast (which gives rise to the placenta). Thus the term PSC refers to the stem cells that contribute to all three germ layers, mesoderm, ectoderm and endoderm, but not to the trophoblast.
During early embryogenesis, the growing morula develops a central cavity and becomes the blastocyst [3] . A fully developed blastocyst contains cells that are precursors for extraembryonic tissues and a distinct group of cells called the inner cell mass (ICM) [4] . The cells of the ICM are also pluripotent and can give rise to all three germ layers of the developing embryo [5] .
Another potential source of PSC ( Figure 1 ) that could be generated by appropriate manipulation, are embryonic germ cells (EG). EG are ex vivo derivates from primordial germ cells (PGC) [6] . Precursors of PGC are the first population of stem cells that can be identified in a mouse embryo at the beginning of gastrulation in the proximal primitive ectoderm (epiblast), a region adjacent to the extraembryonic ectoderm [7] . These founder cells subsequently move through the primitive streak and give rise to several extra-embryonic mesodermal lineages and to germ cells. From a developmental point of view, PGC are the most important population of stem cells because as precursors of germ cells (sperm and oocytes) they are responsible for passing genetic information to the next generation [8] . However, if isolated from the developing embryo and cultured ex vivo, these cells are mortal and undergo terminal differentiation [9] . They do not complement blastocyst development and, even more surprising, PGC nucleus after transferring into enucleated oocyte do not establish clonote.
An explanation for this is the fact that PGC are "protected from uncontrolled" expansion by epigenetic modification/erasure of the somatic imprint on so-called somatic imprinted genes (e.g., H19 and Igf2) [10] . This process occurs very early during development, at a time when the PGC begin to migrate to the genital ridges [11] and it is one of the basic mechanisms that prevents i) their uncontrolled proliferation, ii) initiation of potential parthenogenesis and more importantly iii) teratoma formation [12] . PGC, however, if plated over murine fetal fibroblasts in the presence of selected growth factors (leukemia inhibitory factor, (LIF); basic fibroblast growth factor, (bFGF); and kit ligand (KL), [13] may undergo epigenetic changes in in vitro culture conditions and regain the somatic imprint and become an immortalized population of PSC, the embryonic germ cells (EG) [6] . We hypothesize that erasure of somatic imprint may occur similarly as in PGC also in other PSC deposited around the same time during development in the body and may be a reason why these cells if isolated from the adult tissues may not contribute to neither blastocyst development nor are ineffective in clonote generation ( Figure 2 ).
An important message, however, is that in certain conditions as shown on the example of PGC to EG transition, the erased somatic imprint could be re-established again. EG in many aspects are equivalent to ES cells [14] . Both ES and EG contribute to all three germ layers including the germ cell lineage after injection into a blastocyst. Moreover, their nuclei are again able to establish formation of clonotes after nuclear transfer into enucleated oocytes.
Next, since during gastrulation three distinct germ layers of cells are established, it is believed that the embryo must possess three stem cell types specific for mesoderm, ectoderm and endoderm. These cells are multipotent stem cells which subsequently give rise to monopotent stem cells specific for tissues/organs that develop from a given germ layer (Table II) . For example, multipotent mesodermal stem cells give rise to monopotent hematopoietic, skeletal muscle, heart, endothelial, and mesenchymal tissue-committed stem cells, multipotent endodermal stem cells give rise to monopotent liver, pancreas, and gut epithelium, while ectodermal multipotent stem cells give rise to monopotent brain, peripheral ganglions and nerves, eye, epidermis and skin tissues.
Are pluripotent stem cells (PSC) residing in the adult tissues -theoretical considerations?
In order to classify stem cell as PSC several criteria have to be fulfilled. First, such cells as mentioned in Table I have to be able in in vitro cultures to give rise to more differentiated stem cells committed to cells from all three germ layers. Second, a golden standard to demonstrate pluripotentiality is in vivo contribution to blastocyst development. Accordingly, PSC if injected/aggregated with cells from inner cell mass of the blastocyst should be able to give rise to cells from all three germ layers (meso-, endo-, ecto-derm) including gametes. Third, in a similar more stringent assay known as tertraploid complementation potential PSC could give rise to a whole embryo. For example if PSC is transduced with gene encoding with green fluorescence protein (GFP) it will give rise to GFP + chimera (blastocyste complementation) or GFP + mouse (tertraploid complementation).
Several types of stem cells recently identified in adult tissues, mainly bone marrow (BM) or cord blood (CB) were postulated to be closely related to compartment of PSC. According to the published data these cells possess differentiation potential into cells from more than one germ layer. These cells were described as MSC -mesenchymal stem cells, MAPC -multipotent adult progenitor cells, MIAMI -marrow isolated adult multilineage inducible cells or MASC -Multipotent Adult Stem Cells. It is likely that these are similar/overlapping populations of non-hematopoietic stem cells that were detected by different investigators using different experimental strategies and hence were assigned different names.
Nevertheless, so far not one of the proposed PSC isolated from the adult tissues contributed in a reproducible way to blastocyst development. Some of the positive data showing a presence of candidate cells in developing embryo could be rather explained by a survival of tested cells in the developing tissues without their true differentiation/contribution to different organs. This raises the question that if true PSC reside in adult tissues, and, if so, then why these cells do not contribute to blastocyst development. Table III lists some of the most likely explanations.
First, it is possible that PSC which reside in the adult tissues change during development requirement for appropriate growth factors/cytokines that are required for stimulation of embryonic stem cells. Second, it is likely that these cells isolated from adult tissues are more slowly cycling and therefore they are out-competed in the developing blastocyst by rapidly proliferating embryonic stem cells. Third, it is possible that these cells, similarly as PGC, early in their development erase their proper somatic imprint, which is crucial to maintain the ability of PSC to contribute to blastocyst development. This phenomenon was mentioned in the previous paragraph.
Current strategies to obtain PSC from non-embryonic tissues
The stem cells isolated from adult tissues are a non-controversial source of stem cells for therapy. Figure 3 shows that by employing different strategies there are several attempts to obtain primitive PSC for potential regeneration purposes (stem cell plasticity, isolation from adult tissues and nuclear reprogramming).
Phenomenon of stem cell plasticity
This approach is based on an assumption that stem cells are "plastic" and thus could transdedifferentiate into stem cells committed for various non-hematopoietic organs and tissues [15] . For this phenomenon to occur requires i) a parallel switch of commitment in the compartment of monopotent stem cells or ii), as postulated, a step back in the differentiation process of monopotent stem cells with their de-differentation into multipotent (one germ layercommitted) or even pluripotent (three germ layer-committed) stem cells. This, possibility was bolstered at that time by several reports that demonstrated the remarkable regenerative potential of hematopoietic stem cells (HSC) in animal models, for example, after heart infarct [16] , stroke [17] , spinal cord injury [18] and liver damage [19] . However since these first exciting and promising reports, the role of BM-derived HSC in the repair of damaged organs has become controversial [20, 21] . Further experiments with highly purified populations of HSC showed them not to be effective in regenerating damaged heart [22] or brain [23] . Surprisingly, during all of these deliberations concerning stem cell plasticity and the potential contribution of bone marrow (BM)-, mobilized peripheral blood (mPB)-or cord blood (CB-derived) stem cells to organ regeneration, the concept these tissues may contain heterogeneous populations of stem cells was not taken into careful consideration [20, 24] . Thus regeneration studies demonstrating a contribution of donor-derived BM, mPB or CB cells to non-hematopoietic tissues without addressing a possibility that these cells contain, in addition to HSC, other non-hematopoietic stem cells has led to misleading interpretations. Thus, the "positive" data supporting stem cell plasticity or "trans-dedifferentiation of stem cells" can be re-interpreted by the fact that adult tissue-derived stem cells are heterogeneous and that organs may contain different types of stem cells including perhaps a rare population of PSC. We propose that these cells and not HSC, were responsible for positive results with tissue/organ regeneration after infusion of BM-, mPB-or CB-derived cells.
Potential PSC candidates identified in adult tissues
In the past few years several potential populations of stem cells have been described with the ability to differentiate into cells from more than one germ layer. These cells will be discussed briefly below, and the similarities between these versatile populations of stem cells indicated (Table IV) . It is very likely that several investigators using different isolation strategies described the same populations of stem cells but gave them different names according to circumstance.
Mesenchymal Stem Cells (Multipotent Mesenchymal Stromal Cells)-MSC are fibroblastic cells that are essential in forming the hematopoietic microenvironment in which HSC grow and differentiate [25] . These cells, however as postulated contribute to the regeneration of mesenchymal tissues (e.g., bone, cartilage, muscle, ligament, tendon, adipose and stroma) [26] . It is likely that MSC may be contaminated by other populations of primitive non-hematopoietic stem cells. This possibility should be considered whenever a "transdedifferentiation" of MSC into cells from other germ layers is demonstrated. Because various inconsistencies have come to light in the field of MSC research, the International Society for Cellular Therapy recently recommended avoiding the name of MSC stem cells and changing it to multipotent mesenchymal stromal cells instead [27] . The phenotype of these cells is shown in Table IV .
Multipotent Adult Progenitor Cells (MAPC)-MAPC are isolated from BM as well from various adult organs as a population of CD45 − GPA-A − adherent cells and they display a similar fibroblastic morphology to MSC [28] . Interestingly MAPC are the only population of BMderived stem cells that, so far as is known, contribute to all three germ layers after injection into a developing blastocyst, indicating their pluripotency [28] . The contribution of MAPC to blastocyst development, however, requires confirmation by other, independent laboratories. The phenotype of these cells is summarized in Table IV .
Marrow-isolated adult multilineage inducible (MIAMI) cells-This population of cells
was isolated from human adult BM by culturing BM MNC in low oxygen tension conditions on fibronectin [29] . MIAMI cells were isolated from the BM of people ranging from 3-to 72-years old. Colonies derived from MIAMI cells expressed several markers for cells from all three germ layers, suggesting that, at least as determined by in vitro assays, they are endowed with pluripotency. However, these cells have not been tested so far for their ability to complete blastocyst development. The potential relationship of these cells to MSC and MAPC described above is not clear, although it is possible that these are overlapping populations of cells identified by slightly different isolation/expansion strategies. Table IV shows phenotype of MIAMI cells.
Multipotent Adult Stem Cells (MACS)-These
cells express pluripotent-state-specific transcription factors (Oct-4, Nanog and Rex1) and were cloned from human liver, heart and BM-isolated mononuclear cells [30] . MACS display a high telomerase activity and exhibit a wide range of differentiation potential. Again the potential relationship of these cells to MSC, MAPC and MIAMI described above is not clear, although it is possible that these are overlapping populations of cells identified by slightly different isolation/expansion strategies. The phenotype of these cells is shown in Table IV .
Very Small Embryonic Like (VSEL) Stem Cells-Recently a homogenous population of rare (~0.01% of BM MNC) Sca-1 + lin − CD45 − cells was identified by our team in murine BM. They express (as determined by RQ-PCR and immunhistochemistry) markers of pluripotent stem cells such as SSEA-1, Oct-4, Nanog and Rex-1 and Rif-1 telomerase protein [31] . Direct electron microscopical analysis revealed that VSEL (2-4 μm in diameter) display several features typical for embryonic stem cells such as i) a large nucleus surrounded by a narrow rim of cytoplasm, and ii) open-type chromatin (euchromatin). Interestingly, these cells despite their small size possess diploid DNA and contain numerous mitochondria. VSEL, however, do not express MHC-1 and HLA-DR antigens and are CD90 − CD105 − CD29 − (Table  IV) . It is important to emphasize that with VSEL purification for the first time has been described at the single cell level i) a sorting procedure, ii) the morphology and iii) the surface markers of potential PSC isolated from the adult tissues. Recently, a very similar population of cells that show similar morphology and markers to murine BM-derived VSEL was purified from human CB [32] . Evidence has also mounted that similar cells are also present in the human BM, in particular in young patients. They are also detectable in other organs including thymus, heart, pancreas, brain, kidney, lungs and liver (Figure 4) . It is anticipated that VSEL could become an important source of pluripotent stem cells for regeneration. At this point, however, it is not clear whether VSEL contribute to the blactocyst development.
Reprogramming of somatic cells
Recent evidence shows that an appropriate "cocktail" of expression vectors encoding four transcription factors such as Oct-4, Sox2, Myc and Klf4 can reprogram murine fibroblasts to an embryonic status. Such manipulation reawakens silenced segments in the genome of already differentiated cell and reestablishes pluripotency of its nucleus [33, 34] . This interesting approach was already confirmed by three independent laboratories. Cells from the clones of cells developmentally reverted by this strategy contribute to blastocyst development not only in standard assay but also give rise to the development of a whole embryo during tetraploid complementation assay. Cells generated by this strategy, however have the potential to develop teratomas if injected into syngeneic mice. Thus, the potential clinical application of this strategy to obtain PSC by "debugging cellular reprogramming" by multiple transduced genes requires further validation.
If we compare reprogrammed somatic cells (e.g., fibroblasts) and VSEL, important analogies and differences occur ( Figure 5 ). On one hand, fibroblasts to be transduced with the cocktail of transcription factors, in contrast to VSEL possess a proper somatic imprint on maternal and paternal chromosomes. On the other hand, however, VSEL, which our preliminary data already suggests erased somatic imprint, have constitutive expression of all these genes that have to be first over-expressed in fibroblasts (e.g., Oct-4, Sox-2, Myc and Klf4). Therefore, one of the potential strategies to obtain stem cells that will display all the features of PSC (including potential for blastocyst complementation) would be "debugging cellular reprogramming" by transducing cells by multiple transcription factors (Oct-4, Sox-2, Myc and Klf4) (1 st scenario). The other one would rely on the re-establishment of the proper somatic imprint in VSEL (2 nd scenario). Our team is currently focused on this second possibility -re-establishment of a proper somatic imprint in VSEL.
Germ lineage a mother lineage of all cell lineages in the body -PSC as germ line-derived stem cells deposited in adult tissues
True PSC are found in the developing embryo (Figure 1) . Thus, the presence of potential PSC in adult tissues raises the possibility that these cells could be deposits for the embryonic development, in particular descendants from the most primitive stem cells from the germ line.
To support this notion, it is accepted, that from the developmental and evolutionary point of view, the main goal of the multicellular organism is to pass genes to the next generation and this process is orchestrated by the appropriate interplay between germ and somatic cell lines [35] . The germ line carries the genome (nuclear and mitochondrial DNA) from one generation to the next generation and is the only cell lineage which retains true developmental totipotency. In this context we can envision that placenta and all somatic cell lines are descendants from the germ line and help germ cells to accomplish this mission effectively (Figure 2 ).
To support this concept, we can envision a zygote, which derives directly during conception from the fusion of two germ cells (female oocyte and male sperm) as the most primitive totipotent germ stem cell able to form both embryo and extra-embryonal tissues (placenta). In a zygote, haploid DNA derived from an oocyte is combined with haploid DNA of a male germ cell, sperm, and thus the zygote could be envisioned as a mother cell to the germ lineage which "down the road" will give rise to i) more differentiated cells from the germ lineage (to ensure transfer of genome to the next generation) and ii) other somatic lineages that will provide the soma to fulfill this mission. These somatic cells will derive "bud out" from the germ lineage during embryogenesis. Figure 2 presents this concept showing "a circle of reproductive life" which begins with the establishment of the most primitive germ line cell (zygote), which gives rise to somatic lineages (meso-, ecto-and endoderm) and most importantly germ cells (oocytes or sperm) which ensure transfer of DNA to the next generation. In this context the germ lineage, in order to pass genes to the progeny, must establish an adult organism that will provide a "vehicle" soma/body to fulfill this mission [8, 14, 35] . Figure  1 ). At this time of development, however some level of specification already occurs and the trophoectoderm "buds out" from the germ line (Figure 2 ). Trophoectoderm will form the placenta and the remaining part of the blastocyst -ICM will give rise to the epiblast.
Epiblast stem cells (EPSC) as demonstrated experimentally are also pluripotent and retain germ lineage potential as well [4] . EPSC express SSEA-1 (mice), SSEA-3/4 (human), Oct-4 and Nanog. They will give rise to all three germ layers, ecto-, meso-and endoderm including PGC. Thus, the epiblast, through the process of gastrulation, is the source of all stem cells for all the germ layers and stem cells in these layers will give rise to all of the tissues and organs in the embryo. Thus EPSC could be envisioned as a founder population of PSC for multipotent stem cells for ecto-, endo-or mesoderm that give rise to unipotent stem cells that will develop given cell lineages including population of PGC and PGC-derived gonocytes.
We hypothesize that pluripotent EPSC are deposited during gastrulation in developing embryo as stem cells initiating development of various organs (Figure 2) [35, 36] . Furthermore, there is also some additional evidence that some epiblast-derived PGC themselves, during migration through the embryo properly on their way to the genital ridges, might go astray and seed to peripheral tissues [37] . We believe that population of small Oct-4 + SSEA-1 + CXCR4 + -which we described recently and purifed from BM and non-hematopoietic organs (VSEL) is closely related to EPSC. The current work in our laboratory will soon answer if VSEL could be efficiently employed in the regenerative medicine or whether they are merely developmental remnants found in the BM that cannot be harnessed effectively for regeneration. We hypothesize that re-establishment of a proper somatic imprint in these cells is a key factor to their pluripotency.
Physiological and Pathological consequences of presence of PSC in adult tissues -implication for VSEL
Based on our data, we hypothesize that it is very likely that the PSC identified in adult tissues (e.g., VSEL) that express ICM/epiblast/PGC markers such as SSEA-1 (mice), SSEA-3/4 (human), Oct-4 and Nanog are populations of PSC that were deposited in these tissues early during gastrulation/embryogenesis and are derived mostly from epiblast stem cells and, in addition, from some rare migrating PGC that went astray from their major migratory route to the genital ridges. One of the properties of VSEL is that they are a mobile pool of stem cells that could be released during stress situations (e.g., heart infarct, stroke) from the tissue niches into peripheral blood [38] .
Since VSEL may differentiate in in vitro cultures into cells from all three germ layers, the question remains, however, whether these PSC can continuously contribute in adult life to the renewal of other tissue specific stem cells, including, for example, population of HSC in BM. Evidence accumulates that VSEL isolated from the adult tissues are an alternative not controversial from an ethical point of view source of stem cells for regenerative medicine. However, there are several answers to this timely question, especially in view of the current widely performed clinical trials with BM-derived stem cells in cardiology and neurology, before VSEL will find potential application in regenerative medicine.
First, there is the obvious problem of isolating a sufficient number of VSEL from the BM. The number of these cells among BM MNC is very low (e.g., VSEL represent 1 cell in 10 4 -10 5 of BM MNC). Furthermore, our data show that these cells are enriched in the BM of young mammals and their number decreases with age. It is also likely that VSEL, if released from the BM into PB during stress situations, even if they are able to home to the areas of tissue/organ injury, play a role only in regeneration of minor tissue injuries. Heart infarct or stroke, on the other hand, would be considered to involve severe tissue damage beyond the capacity of these rare cells to effectively repair. Second, the allocation of these cells to the damaged areas depends on homing signals that may be inefficient in the presence of proteolytic enzymes released from leukocytes and macrophages associated with damaged tissue. For example, matrix metalloproteinases (MMPs) released from inflammatory cells may degrade chemoattracting agents (e.g., stromal derived factor-1) locally and thus, perturb homing of CXCR4 + VSEL to the damaged tissues. Thus, VSEL may potentially circulate as a homeless population of stem cells in peripheral blood and return to BM or home to other organs. Third, in order to reveal the full regenerative potential, these cells have to be fully functional. We cannot exclude the possibility that VSEL, while residing/being "trapped" in the BM, are not fully functional but remain "locked" in a dormant state and need the appropriate activation signals by unidentified factors. As mentioned above, they have also most likely erased somatic imprint, which may limit their pluripotentiality -particularly in in-vivo assays based on blastocyst complementation. Thus, we have to develop efficient ex vivo culture conditions that will allow for efficient expansion of VSEL without supportive feeder layer cells (e.g., C2C12, BM-derived fibroblasts). On the other hand, the controlled modulation of somatic imprint status in VSEL for example as we hypothesize -a proper de novo methylation of somatic imprinted genes on maternal and paternal chromosomes could increase a regenerative power of these cells.
There is also another side of the coin. Accordingly, in pathological situations, VSEL or cells related to this population could contribute to tumor development. In 1855, Virchow proposed the "embryonal -rest hypothesis" of tumor formation, based on histological similarities between tumors and embryonic tissues. This theory was later supported by another pathologist, Julius Conheim, who suggested that tumors develop from residual embryonic remnants "lost" during developmental organogenesis.
The VSEL recently identified in adult tissues could fully support Virchow's concept. First, if the genomic imprint in these cells is not erased they may retain post-developmental in vivo pluripotency and grow teratomas and teratocarcinomas [39] . Second, if they are closely related to migratory PGC, which go astray from the major migratory route to the genital ridges, they may ultimately give rise to e.g., germinomas and seminomas [40] . Third, if these cells acquire critical mutations, they may develop into the several types of pediatric sarcomas (e.g., rhabdomyosarcoma, neuroblastoma, Ewing-sarcoma, Willms tumor) [41] . In support of this, there is a strong correlation with the number of these Oct-4 + cells which persist in postnatal tissues and the coincidence with these types of tumors in pediatric patients. Finally, it is possible that these cells, if mobilized at the wrong time into peripheral blood, and deposited in areas of chronic inflammation, instead of playing a role in regeneration may contribute to the development of some other malignancies (e.g., stomach cancer) [42] . To support this further, several tumor types may express embryonic markers including Oct-4 and, as reported, BMderived stem cells that may develop in the presence of carcinogens several sarcomas including teratomas [43] . Furthermore, we hypothesize that VSEL hiding among bone marrow derived fibroblasts could also be responsible for sarcoma formation in MSC cultures [44] . These cells could also potentially be involved in tumor expansion and growth by providing vessels and stroma cells for growing cancer. In this case, a tumor signals to mobilize and chemoattract circulating VSEL which would wrongly recognize expanding tumor tissue as regenerating tissue. In fact, similar mechanisms have been postulated for circulating endothelial progenitor cells [45] .
Finally, it was proposed recently that cancer is a chromosomal rather than a genetic disease [46] . Accordingly, carcinogenesis could be initiated by random aneuploidies induced by cancerogenes or spontaneously, which unbalances genes and leads to selection of cancer cells. In this context VSEL could be a potential fusion partner for somatic cells. VSEL would provide several transcripts characteristic for early developmental cells (e.g., Oct-4), and somatic cells would supply properly imprinted chromosomes. The formation of such heterokaryons could be a first step in selection of anueploid "immortal" cancer cells. All these possibilities of how VSEL could hypothetically contribute to cancer initiation and expansion are shown in Figure  6 .
Conclusions
The search for PSC that could be applied in regenerative medicine continues. Accumulating evidence demonstrates that adult tissues contain cells that express early developmental markers such as stage specific embryonic antigen (SSEA) and transcription factors Oct-4 and Nanog. These are the markers characteristic for embryonic stem cells (ESC), epiblast stem cells (EPSC) and primordial germ cells (PGC). The presence of these stem cells in adult tissues including bone marrow, epidermis, bronchial epithelium, myocardium, pancreas and testes supports the concept that adult tissues contain some population of PSC that is deposited in embryogenesis during early gastrulation. These cells potentially could be employed in regenerative medicine. We hypothesize, that described by our team VSEL will become an important source of PSC for regenerative medicine. For additional readings on the use of bone marrow transplantation for autoimmunity, we refer the reader to the companion papers published in this special issue [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] . The most primitive stem cell is a totipotent zygote or first blastomer that derives from the first division of the zygote. A totipotent stem cell divides to give cells that will form both embryo and placenta. Pluripotent stem cells (PSC) that contribute only to embryo development are cells isolated from the inner cell mass (ICM) of a blastocyst, from epiblast of cylinder-stage embryo (EPSC) or could be derived in ex vivo cultures from epiblast-derived primordial germ cells (PGC) -as a population of so called embryonic germ cells (EG) . PSC contribute to all three germ layers in the developing embryo (ecto-, meso-and endoderm). Multipotent stem cells give rise to monopotent stem cells that are committed to particular organs/tissues. We hypothesize that VSELs could be a population of epiblast-derived PSC that is deposited in various tissues (e.g., BM) and survives into adulthood. From the developmental and evolutionary point of view the germ line (shown in red) carries the genome (nuclear and mitochondrial DNA) from one generation to the next and all somatic cell lines bud out (grey color) during ontogenesis from the germ line to help germ cells accomplish this mission effectively. The germ potential is established in the fertilized oocyte (zygote), and subsequently retained in the morula, ICM, EPSC, PGC and mature germ cells (oocytes and sperm). The first cells that bud out from the germ lineage are trophoectodermal cells that will give rise to the placenta. Subsequently during gastrulation EPSC are a source of pluripotent stem cells for all three germ layers (meso-, ecto-and endoderm) and PGC. We hypothesize that at this stage some EPSC could be deposited as Oct-4 + PSC in peripheral tissues/organs (red circles). Similarly, some migrating PGC could go astray from their major migratory route to the genital ridges and become deposited as well. Furthermore, it is also possible that similarly as PGC, other EPSC deposited in the developing tissues undergo erasure of their somatic imprint (yellow arrows). This mechanism of erasure will protect the developing organism from the possibility of teratoma formation. However, it will affect some of the aspects of the pluripotentiality of these cells (e.g., potential of these cells to contribute to blastocyst development). Fibroblasts (MSC) to be transduced with cocktail of transcription factors, in contrast to VSEL possess a proper somatic imprint on maternal and paternal chromosomes. VSEL as we hypothesize erased somatic imprint, but have constitutive expression of all these genes that have to be over-expressed in fibroblasts during their reprogramming (e.g., Oct-4, Sox-2, Myc and Klf4). Therefore potential strategies to obtain PSC would be "debugging cellular reprogramming" by transducing cells by multiple genes (1 st scenario) or to re-establish somatic imprint in VSEL (2 nd scenario). Our team is currently focused on the second possibility -on reestablishing somatic imprint in VSEL. A -VSEL may give rise to cancer (stem) cell (dark irregular cell) if it does not erase somatic imprint or acquires mutations and, as a result of this, gives rise to teratomas/teratocarcinomas or pediatric sarcomas (e.g., rhabdomyosarcoma, neuroblastoma, nephroblastoma) respectively. B -VSEL may fuse due to the chronic inflammation/fusogenic agent with normal somatic cell (white box with dark nucleus) and give rise to heterokaryon (blue cells with nucleus). Tetraploid heterokaryon undergoes subsequent selection and gives rise to the aneuploid cancer (stem) cell. C -VSEL may indirectly contribute to tumorogenesis by providing vasculature and stroma cells for growing tumor tissue. Table III Potential explanations why PSC isolated from adult tissues do not contribute to blastocyst development.
-PSC residing in adult tissues need proper activation -PSC residing in adult tissues lose responsiveness to fetal factors -Differences in cycling time between embryonic and PSC cells isolated from adult tissues -Erasure of somatic imprint (proper methylation of maternal and paternal inherited genes)
